Provider Consolidation and Site-of-Care Shifts Present Oncology Market Access Challenge
This article was originally published in RPM Report
Expanding Medicaid enrollments in 2014 could have a significant impact on the number of institutions that will meet disproportionate share thresholds and qualify for 340B pricing. Those institutions, in turn, may go on the hunt to purchase more oncology practices. That chain of events is just one of the interlocking pieces of a shifting market map for oncology treatments in coming years.